Wed, July 31, 2024
Tue, July 30, 2024
Mon, July 29, 2024

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $18 on, Jul 30th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-18-on-jul-30th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $18 on, Jul 30th, 2024.

Serge has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $18 on, Wednesday, May 15th, 2024

Publication Contributing Sources